Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
PaperCitations, authors & open-access status
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 438 citations, 2014 year and closed oa status.
438
Citations
2014
Year
closed
OA Status